Naltrexone Hydrochloride Aop Orphan Pharmaceuticals (Naltrexone Hydrochloride)

Naltrexone works by competitively binding to μ‑, κ‑ and δ‑opioid receptors without activating them. This blocks both endogenous opioids and external opioid drugs from stimulating the receptors, preventing the reinforcing and euphoric signals that drive dependence, thereby reducing cravings and the risk of relapse.

The exact dose of Naltrexone Hydrochloride is determined by the prescribing clinician based on the individual’s medical condition, treatment goals, and response. Typical regimens involve a once‑daily oral tablet, but the prescriber may adjust the strength or frequency to suit the patient’s needs.

Safety data for Naltrexone Hydrochloride in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified health professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any required temperature controls) and assists with import documentation.

The primary alternative for opioid dependence is methadone, a long‑acting opioid agonist that reduces withdrawal symptoms but maintains opioid activity. Naltrexone, by contrast, is an antagonist that blocks opioid receptors, offering a non‑opioid approach that eliminates opioid effects. For alcohol dependence, acamprosate is another option; unlike Naltrexone, acamprosate works on glutamate pathways rather than opioid receptors.

Naltrexone Hydrochloride tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use. No refrigeration is required for this oral formulation.

The medication is supplied as oral tablets that are taken with water, usually once daily as directed by a healthcare provider. Patients should follow the prescriber’s instructions regarding timing (e.g., after opioid detoxification) and should not consume opioid‑containing products while on therapy.

Serious risks include hepatotoxicity, which may manifest as elevated liver enzymes or liver injury, and severe depression that can lead to suicidal thoughts. Allergic reactions such as rash, swelling, or anaphylaxis are also possible. Patients should be monitored regularly for liver function and mood changes, and any severe symptoms should prompt immediate medical attention.

Naltrexone is contraindicated in individuals with acute hepatitis, severe liver failure, or known hypersensitivity to the drug. It should also be avoided in patients currently receiving opioid analgesics or opioid maintenance therapy, as it can precipitate withdrawal. Clinicians must assess liver function and opioid use status before initiating treatment.